(Q35993120)

11 August 2017

Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests (English)

1 reference

11 August 2017

1 reference

1

Twelves CJ

1 reference

11 August 2017

Dobbs NA

2

1 reference

11 August 2017

Michael Y

3

1 reference

11 August 2017

Summers LA

4

1 reference

11 August 2017

Gregory W

5

1 reference

11 August 2017

Harper PG

6

1 reference

11 August 2017

Rubens RD

7

1 reference

11 August 2017

Richards MA

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 1992

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

66

1 reference

11 August 2017

4

1 reference

11 August 2017

765-769

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1992.353

11 August 2017

0 references

cites work

Clearance and biologic half-life as indices of intrinsic hepatic metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977407

Metabolism of epirubicin to glucuronides: relationship to the pharmacodynamics of the drug.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977407

Is glucuronidation truly preserved in patients with liver disease?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977407

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977407

Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977407

Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977407

High-dose epirubicin as primary chemotherapy in advanced breast carcinoma: a phase II study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977407

Effectiveness of scalp cooling in reducing alopecia caused by epirubicin treatment of advanced breast cancer

11 July 2018

1 reference

12 December 2020

Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia

1 reference

12 December 2020

Epirubicin in breast cancer patients with liver metastases and abnormal liver biochemistry: Initial weekly treatment followed by rescheduling and intensification

1 reference

12 December 2020

Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival

1 reference

12 December 2020

Pharmacokinetics of weekly low dose doxorubicin

1 reference

12 December 2020

Phase II study of doxorubicin versus epirubicin in advanced breast cancer

1 reference

12 December 2020

Biliary excretion and pharmacokinetics of 4'epidoxorubicin (epirubicin) in advanced cancer patients

1 reference

12 December 2020

Metabolism of epidoxorubicin in animals: absence of glucuronidation

1 reference

12 December 2020

Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer

1 reference

12 December 2020

Pharmacokinetics of 4'-epi-doxorubicin in man

1 reference

12 December 2020

Acute doxorubicin toxicity. Relationship to pretreatment liver function, response, and pharmacokinetics in patients with acute nonlymphocytic leukemia

1 reference

12 December 2020

Early-phase pharmacokinetics of doxorubicin in non-hodgkin lymphoma patients

1 reference

12 December 2020

Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases

1 reference

12 December 2020

Measurement of epidoxorubicin and its metabolites by high-performance liquid chromatography using an advanced automated sample processor

1 reference

12 December 2020

Pharmacokinetics of adriamycin, adriamycinol, and antipyrine in patients with moderate tumor involvement of the liver

1 reference

12 December 2020

Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma

1 reference

12 December 2020

STRIPE: an interactive computer program for the analysis of drug pharmacokinetics

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1992.353

1 reference

11 August 2017

1 reference

11 August 2017

1 reference